OptimizeRx Achieves Rule of 40 Status Amid Record 2025 Performance and $10 Million Share Buyback
Market Chameleon (Fri, 6-Mar 7:50 AM)
Optimizerx Earnings Call: Profits Strong, Growth Cautious
at www.tipranks.com (Fri, 6-Mar 7:07 PM)
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty
at www.benzinga.com (Fri, 6-Mar 1:09 PM)
Analysts’ Top Healthcare Picks: OptimizeRx (OPRX), Roche Holding AG (RHHVF)
at www.tipranks.com (Fri, 6-Mar 8:30 AM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Fri, 6-Mar 7:20 AM)
OptimizeRx signals $109M-$114M revenue target for 2026 as market shifts drive cautious outlook
at seekingalpha.com (Thu, 5-Mar 6:46 PM)
at www.tipranks.com (Thu, 5-Mar 5:45 PM)
OptimizeRx Authorizes $10 Million Share Repurchase Program
at www.tipranks.com (Thu, 5-Mar 4:33 PM)
OptimizeRx Non-GAAP EPS of $0.51 beats by $0.29, revenue of $32.2M beats by $1.29M
at seekingalpha.com (Thu, 5-Mar 4:04 PM)
Lake Street Sticks to Their Buy Rating for OptimizeRx (OPRX)
at www.tipranks.com (Thu, 5-Mar 11:17 AM)
Here are the major earnings after the close Thursday
at seekingalpha.com (Thu, 5-Mar 10:00 AM)
OptimizeRx Q4 2025 Earnings Preview
at seekingalpha.com (Wed, 4-Mar 5:35 PM)
Lake Street Reaffirms Their Buy Rating on OptimizeRx (OPRX)
at www.tipranks.com (Mon, 2-Mar 10:35 AM)
